YTHDC1 and metabolic dysfunction-associated steatohepatitis: Adult Ythdc1‐HKO mice exhibit impaired glucose homeostasis, severe liver injury, inflammation, and fibrosis, which further promote the pathogenesis of NASH and HCC.